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Figure 1:  Sagittal view of CT scan abdomen and pelvis with contrast demonstrating 









Calcium (8.2-10.4 mg/dL) 9.8 10.5 11.9 (corrected - 12.4) 7.0 (corrected 8.7)
Albumin (3.5-5.0g/dL) 4.6 4.2 3.4 1.9
Ionized Calcium (4.6-5.4 mg/dL) - - 6.45 -
eGFR (>60mL/min/1.73m2) 96 46 36 14
BUN (10-26mg/dl) 19 29 79 89




































Vitamin D, 25 OH total (30-100ng/mL) 46
Vitamin D, 1,25-Dihydroxy (18-64pg/mL) 95 and 77
Intact PTH (14-72 pg/mL) 12
PTHrP (<2.0 pmol/L) 1.1
 
  
Figure 2:  CT scan abdomen and pelvis with IV contrast demonstrating a large 15.7cm by 
8.4cm mass which appears to be centered within the left lobe of the liver but is exophytic, 
abutting the pancreas and stomach but not appearing to originate in either of these organs.   
Figure 3:  Sigmoid biopsy in formalin showing invasive moderately differentiated 
adenocarcinoma.  Depth of involvement cannot be determined. 
Figure 4:  Liver core biopsy showing high grade malignant neoplasm consistent with epithelioid 
mesothelioma.  Immunoperoxidase stain for inhibin, CAM 5.2, CK7, calretinin, WT1 were 
positive. This malignant neoplasm is histologically distinct from his rectal adenocarcinoma and 
represents a synchronous secondary primary neoplasm.
Table 1:  Routine laboratory evaluation 
reported elevated calcium level with diagnosis 
of moderately differentiated adenocarcinoma 
of the sigmoid colon and epitheloid 
mesothelioma. 
Table 2:  Hypercalcemia workup showed no 
evidence of osteolytic lesions on imaging, 
normal 25 OH vitamin D, low intact PTH, 
normal PTHrP and absent monoclonal proteins 
on serum and urine protein electrophoresis. 
1,25 OH vitamin D was high on two samples.
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